Biomedical Applications of Hard Materials

View at publisher
Authors: Fatema Tuz Zohera, Abul Kalam Azad, Madhusmruti Khandai
Cited by: 0

Abstract

Hard materials are of utmost importance in the biomedical area, serving either as toxins or treatments. Additionally, they are employed in the field of medicine for the purposes of diagnosis and therapy, with a notable multitude of applicability. In addition to established therapies, a range of novel application possibilities are appearing and garnering the attention of academics worldwide. Materials represent a revolutionary change in the realm of delivery of drugs including their use for healthcare purposes. Being able to be used in many ways and adjust to different situations has not only improved the results of therapy but also greatly lessened the negative consequences. A wide range of hard materials are utilized in the domains of dental and medical care. It provides an explanation of the present metallic, ceramic, and polymer materials used in healthcare, along with the associated challenges. Additionally, it explores conceivable future materials that could address these issues. The term “hard biomaterial” is initially contrasted with “soft Biomaterial”, and the importance of smart link among hard materials with biological tissue, known as biosis-abiosis, is illustrated. The discussion focuses on the tissue compatibility of titanium, as well as the surface treatment methods used to enhance its ability to interact with hard tissues. The present challenges in this area are also addressed, along with the need for more study in materials science. Additionally, the use of hard materials in the field of regenerative healthcare is explored. Furthermore, the purpose of the article represents to examine the promising developments and potential in biomaterials, which anticipating medical settings in which they enable accurate, specific and individualized drug administration. Biomaterials possess the capacity to fundamentally transform the medical field through the provision of personalized therapies that cater to the unique requirements of each patient. It presents significant potential for enhanced therapeutic effectiveness accompanied by reduced adverse effects, thereby securing greater prospects for pharmaceuticals.

Publication details

Pages
395–413
Publication date
9 January 2026
Language
EN